These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27068780)

  • 1. Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
    Bahig H; Filion E; Vu T; Chalaoui J; Lambert L; Roberge D; Gagnon M; Fortin B; Béliveau-Nadeau D; Mathieu D; Campeau MP
    Pract Radiat Oncol; 2016; 6(5):367-374. PubMed ID: 27068780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy.
    Li F; Zhou Z; Wu A; Cai Y; Wu H; Chen M; Liang S
    Radiat Oncol; 2018 May; 13(1):82. PubMed ID: 29716649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
    Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
    Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
    Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
    Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
    Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
    Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer.
    Ueki N; Matsuo Y; Togashi Y; Kubo T; Shibuya K; Iizuka Y; Mizowaki T; Togashi K; Mishima M; Hiraoka M
    J Thorac Oncol; 2015 Jan; 10(1):116-25. PubMed ID: 25376512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.
    Liu H; Zhang X; Vinogradskiy YY; Swisher SG; Komaki R; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1017-23. PubMed ID: 22543216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy.
    Li F; Liu H; Wu H; Liang S; Xu Y
    Radiat Oncol; 2021 Apr; 16(1):70. PubMed ID: 33849579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
    Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
    Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Thoracic Radiotherapy an Absolute Contraindication for Treatment of Lung Cancer Patients With Interstitial Lung Disease? A Systematic Review.
    Saha A; Dickinson P; Shrimali RK; Salem A; Agarwal S
    Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):e493-e504. PubMed ID: 35168842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis.
    Yamaguchi S; Ohguri T; Matsuki Y; Yahara K; Oki H; Imada H; Narisada H; Korogi Y
    Int J Clin Oncol; 2015 Feb; 20(1):45-52. PubMed ID: 24610080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease.
    Okumura M; Hojo H; Nakamura M; Hiyama T; Nakamura N; Zenda S; Motegi A; Hirano Y; Kageyama SI; Parshuram RV; Fujisawa T; Kuno H; Akimoto T
    Radiother Oncol; 2021 Aug; 161():47-54. PubMed ID: 34089755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with non-small cell lung cancer.
    Sakagami M; Inokuchi H; Mukumoto N; Itoyama H; Hamaura N; Yamagishi M; Mukumoto N; Matsuda S; Kabata D; Shibuya K
    Radiat Oncol; 2023 May; 18(1):87. PubMed ID: 37217919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.
    Ozawa Y; Abe T; Omae M; Matsui T; Kato M; Hasegawa H; Enomoto Y; Ishihara T; Inui N; Yamada K; Yokomura K; Suda T
    PLoS One; 2015; 10(10):e0140437. PubMed ID: 26460792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon-ion radiotherapy for non-small cell lung cancer with interstitial lung disease: a retrospective analysis.
    Nakajima M; Yamamoto N; Hayashi K; Karube M; Ebner DK; Takahashi W; Anzai M; Tsushima K; Tada Y; Tatsumi K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
    Radiat Oncol; 2017 Sep; 12(1):144. PubMed ID: 28865463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
    Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
    J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
    Robnett TJ; Machtay M; Vines EF; McKenna MG; Algazy KM; McKenna WG
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):89-94. PubMed ID: 10924976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
    Palma DA; Chen H; Bahig H; Gaede S; Harrow S; Laba JM; Qu XM; Rodrigues GB; Yaremko BP; Yu E; Louie AV; Dhaliwal I; Ryerson CJ
    BMC Cancer; 2019 Dec; 19(1):1206. PubMed ID: 31829203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.
    Lee YH; Kim YS; Lee SN; Lee HC; Oh SJ; Kim SJ; Kim YK; Han DH; Yoo IeR; Kang JH; Hong SH
    Cancer Res Treat; 2015 Oct; 47(4):676-86. PubMed ID: 25687856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.